Longitudinal change in basal ganglia volume in patients with Huntington's disease

Elizabeth H. Aylward, Q. Li, O. C. Stine, N. Ranen, M. Sherr, Patrick Ernest Barta, F. W. Bylsma, G. D. Pearlson, Christopher A Ross

Research output: Contribution to journalArticle

Abstract

Cross-sectional MRI studies demonstrating an association between caudate atrophy and symptom severity and duration of symptoms in patients with Huntington's disease (HD) have been assumed to reflect longitudinal changes in basal ganglia, but such neuropathologic progression has never been directly demonstrated. Subjects in the current study were 23 HD patients at various stages of the disorder who had two MRI images at least 10 months apart (mean interimage interval - 20.8 months). We measured volumes of caudate, putamen, and globus pallidus blind to the order of the images. For each structure, we calculated a change score by subtracting the volume obtained on the follow-up imaging from that obtained on the initial imaging. Results indicated significant decreases over time in caudate, putamen, and total basal ganglia volume. Age at onset and length of trinucleotide repeat correlated significantly with amount of volume change in caudate and total basal ganglia, even after controlling for length of interimage interval, duration of disease, and measures of symptom severity. Amount of change in basal ganglia structures was not significantly correlated with neurologic symptom severity at the time of the initial imaging or duration of symptoms. This is the first longitudinal MRI study to document progressive basal ganglia atrophy in HD, and suggests that quantitative neuroimaging with serial MRI may be useful in monitoring effectiveness of potential treatments. In addition, demonstration of greater rate of basal ganglia atrophy in patients with earlier symptom onset suggests that treatment effects may be more quickly observed in this subgroup of patients than in the general HD population.

Original languageEnglish (US)
Pages (from-to)394-399
Number of pages6
JournalNeurology
Volume48
Issue number2
StatePublished - Feb 1997

Fingerprint

Huntington Disease
Basal Ganglia
Atrophy
Putamen
Trinucleotide Repeats
Globus Pallidus
Neurologic Manifestations
Age of Onset
Neuroimaging
Longitudinal Studies
Cross-Sectional Studies
Population

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Longitudinal change in basal ganglia volume in patients with Huntington's disease. / Aylward, Elizabeth H.; Li, Q.; Stine, O. C.; Ranen, N.; Sherr, M.; Barta, Patrick Ernest; Bylsma, F. W.; Pearlson, G. D.; Ross, Christopher A.

In: Neurology, Vol. 48, No. 2, 02.1997, p. 394-399.

Research output: Contribution to journalArticle

Aylward, EH, Li, Q, Stine, OC, Ranen, N, Sherr, M, Barta, PE, Bylsma, FW, Pearlson, GD & Ross, CA 1997, 'Longitudinal change in basal ganglia volume in patients with Huntington's disease', Neurology, vol. 48, no. 2, pp. 394-399.
Aylward, Elizabeth H. ; Li, Q. ; Stine, O. C. ; Ranen, N. ; Sherr, M. ; Barta, Patrick Ernest ; Bylsma, F. W. ; Pearlson, G. D. ; Ross, Christopher A. / Longitudinal change in basal ganglia volume in patients with Huntington's disease. In: Neurology. 1997 ; Vol. 48, No. 2. pp. 394-399.
@article{ad99299abf90475e9230fa38b6eecc42,
title = "Longitudinal change in basal ganglia volume in patients with Huntington's disease",
abstract = "Cross-sectional MRI studies demonstrating an association between caudate atrophy and symptom severity and duration of symptoms in patients with Huntington's disease (HD) have been assumed to reflect longitudinal changes in basal ganglia, but such neuropathologic progression has never been directly demonstrated. Subjects in the current study were 23 HD patients at various stages of the disorder who had two MRI images at least 10 months apart (mean interimage interval - 20.8 months). We measured volumes of caudate, putamen, and globus pallidus blind to the order of the images. For each structure, we calculated a change score by subtracting the volume obtained on the follow-up imaging from that obtained on the initial imaging. Results indicated significant decreases over time in caudate, putamen, and total basal ganglia volume. Age at onset and length of trinucleotide repeat correlated significantly with amount of volume change in caudate and total basal ganglia, even after controlling for length of interimage interval, duration of disease, and measures of symptom severity. Amount of change in basal ganglia structures was not significantly correlated with neurologic symptom severity at the time of the initial imaging or duration of symptoms. This is the first longitudinal MRI study to document progressive basal ganglia atrophy in HD, and suggests that quantitative neuroimaging with serial MRI may be useful in monitoring effectiveness of potential treatments. In addition, demonstration of greater rate of basal ganglia atrophy in patients with earlier symptom onset suggests that treatment effects may be more quickly observed in this subgroup of patients than in the general HD population.",
author = "Aylward, {Elizabeth H.} and Q. Li and Stine, {O. C.} and N. Ranen and M. Sherr and Barta, {Patrick Ernest} and Bylsma, {F. W.} and Pearlson, {G. D.} and Ross, {Christopher A}",
year = "1997",
month = "2",
language = "English (US)",
volume = "48",
pages = "394--399",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Longitudinal change in basal ganglia volume in patients with Huntington's disease

AU - Aylward, Elizabeth H.

AU - Li, Q.

AU - Stine, O. C.

AU - Ranen, N.

AU - Sherr, M.

AU - Barta, Patrick Ernest

AU - Bylsma, F. W.

AU - Pearlson, G. D.

AU - Ross, Christopher A

PY - 1997/2

Y1 - 1997/2

N2 - Cross-sectional MRI studies demonstrating an association between caudate atrophy and symptom severity and duration of symptoms in patients with Huntington's disease (HD) have been assumed to reflect longitudinal changes in basal ganglia, but such neuropathologic progression has never been directly demonstrated. Subjects in the current study were 23 HD patients at various stages of the disorder who had two MRI images at least 10 months apart (mean interimage interval - 20.8 months). We measured volumes of caudate, putamen, and globus pallidus blind to the order of the images. For each structure, we calculated a change score by subtracting the volume obtained on the follow-up imaging from that obtained on the initial imaging. Results indicated significant decreases over time in caudate, putamen, and total basal ganglia volume. Age at onset and length of trinucleotide repeat correlated significantly with amount of volume change in caudate and total basal ganglia, even after controlling for length of interimage interval, duration of disease, and measures of symptom severity. Amount of change in basal ganglia structures was not significantly correlated with neurologic symptom severity at the time of the initial imaging or duration of symptoms. This is the first longitudinal MRI study to document progressive basal ganglia atrophy in HD, and suggests that quantitative neuroimaging with serial MRI may be useful in monitoring effectiveness of potential treatments. In addition, demonstration of greater rate of basal ganglia atrophy in patients with earlier symptom onset suggests that treatment effects may be more quickly observed in this subgroup of patients than in the general HD population.

AB - Cross-sectional MRI studies demonstrating an association between caudate atrophy and symptom severity and duration of symptoms in patients with Huntington's disease (HD) have been assumed to reflect longitudinal changes in basal ganglia, but such neuropathologic progression has never been directly demonstrated. Subjects in the current study were 23 HD patients at various stages of the disorder who had two MRI images at least 10 months apart (mean interimage interval - 20.8 months). We measured volumes of caudate, putamen, and globus pallidus blind to the order of the images. For each structure, we calculated a change score by subtracting the volume obtained on the follow-up imaging from that obtained on the initial imaging. Results indicated significant decreases over time in caudate, putamen, and total basal ganglia volume. Age at onset and length of trinucleotide repeat correlated significantly with amount of volume change in caudate and total basal ganglia, even after controlling for length of interimage interval, duration of disease, and measures of symptom severity. Amount of change in basal ganglia structures was not significantly correlated with neurologic symptom severity at the time of the initial imaging or duration of symptoms. This is the first longitudinal MRI study to document progressive basal ganglia atrophy in HD, and suggests that quantitative neuroimaging with serial MRI may be useful in monitoring effectiveness of potential treatments. In addition, demonstration of greater rate of basal ganglia atrophy in patients with earlier symptom onset suggests that treatment effects may be more quickly observed in this subgroup of patients than in the general HD population.

UR - http://www.scopus.com/inward/record.url?scp=0031037349&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031037349&partnerID=8YFLogxK

M3 - Article

C2 - 9040728

AN - SCOPUS:0031037349

VL - 48

SP - 394

EP - 399

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 2

ER -